Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review

J Núñez, R de la Espriella, G Miñana… - European journal of …, 2021 - Wiley Online Library
Congestion explains many of the signs and symptoms of acute heart failure (AHF) and
disease progression. However, accurate quantification of congestion is challenging in daily …

[HTML][HTML] Quantification and treatment of congestion in heart failure: a clinical and pathophysiological overview

R de la Espriella, E Santas, IZ Reiriz, JL Górriz… - Nefrología (English …, 2022 - Elsevier
Renal sodium and water retention with resulting extracellular volume expansion and
redistribution are hallmark features of heart failure syndromes. However, congestion …

Carbohydrate antigen 125 in congestive heart failure: ready for clinical application?

R Feng, Z Zhang, Q Fan - Frontiers in Oncology, 2023 - frontiersin.org
Congestion is the permanent mechanism driving disease progression in patients with acute
heart failure (AHF) and also is an important treatment target. However, distinguishing …

Tumour biomarkers: association with heart failure outcomes

C Shi, HH van der Wal, HHW Silljé… - Journal of Internal …, 2020 - Wiley Online Library
Background There is increasing recognition that heart failure (HF) and cancer are conditions
with a number of shared characteristics. Objectives To explore the association between …

[HTML][HTML] Cuantificación y tratamiento de la congestión en insuficiencia cardíaca: una visión clínica y fisiopatológica

R de la Espriella, E Santas, IZ Reiriz, JL Górriz… - Nefrología, 2022 - Elsevier
La retención renal de sodio y agua, con la consiguiente expansión y redistribución del
volumen de líquido extracelular, constituye una de las principales características …

Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme

JP Ferreira, M Packer, N Sattar, J Butler… - European Journal of …, 2024 - Wiley Online Library
Aim Vascular congestion may lead to an increase of carbohydrate antigen 125 (CA‐125).
The role of CA‐125 as a biomarker of congestion or for prognosis across the full ejection …

Lung ultrasound in outpatients with heart failure: the wet‐to‐dry HF study

M Domingo, J Lupón, N Girerd, L Conangla… - ESC Heart …, 2021 - Wiley Online Library
Aims In ambulatory patients with chronic heart failure (HF), congestion and decongestion
assessment may be challenging. The aim of this study is to assess the value of lung …

[HTML][HTML] Carbohydrate antigen 125: a biomarker at the crossroads of congestion and inflammation in heart failure

M Kumric, TT Kurir, J Bozic, D Glavas, T Saric… - Cardiac failure …, 2021 - ncbi.nlm.nih.gov
Because heart failure (HF) is more lethal than some of the common malignancies in the
general population, such as prostate cancer in men and breast cancer in women, there is a …

Novel mechanisms in heart failure with preserved, midrange, and reduced ejection fraction

I Lakhani, KSK Leung, G Tse, APW Lee - Frontiers in Physiology, 2019 - frontiersin.org
Heart failure (HF) represents a major epidemic with high morbidity and mortality rates,
imposing a significant burden on healthcare systems worldwide (Savarese and Lund, 2017) …

Carbohydrate antigen 125 for mortality risk prediction following acute myocardial infarction

F Falcão, F Oliveira, F Cantarelli, R Cantarelli… - Scientific Reports, 2020 - nature.com
Abstract Carbohydrate antigen 125 (CA125) is a congestion and inflammation biomarker
and has been proved to be related to a worse prognosis in heart diseases. However, the …